Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women.
about
Vitamin D supplementation for prevention of cancer in adultsVitamin D: link between osteoporosis, obesity, and diabetes?Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled Trial.Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D₃.Effect of vitamin D3-supplementation on bone markers (serum P1NP and CTX): A randomized, double blinded, placebo controlled trial among healthy immigrants living in NorwayThe role of vitamin D in maintaining bone health in older people.Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues?Fragility fracture risk and skeletal muscle function.Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial.Vitamin D: Musculoskeletal health.Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.Dietary reference values for vitamin D25-Hydroxyvitamin D as a Biomarker of Vitamin D Status and Its Modeling to Inform Strategies for Prevention of Vitamin D Deficiency within the Population.Longevity of daily oral vitamin D3 supplementation: differences in 25OHD and 24,25(OH)2D observed 2 years after cessation of a 1-year randomised controlled trial (VICtORy RECALL).Effect of monthly high-dose vitamin D on bone density in community-dwelling older adults substudy of a randomized controlled trial.A Mediterranean-like dietary pattern with vitamin D3 (10 µg/d) supplements reduced the rate of bone loss in older Europeans with osteoporosis at baseline: results of a 1-y randomized controlled trial
P2860
Q24193850-6BB80DEF-05B0-40C2-85EA-BAE979A44CE9Q26828851-0084768B-967E-4BDE-AEF1-0CAE92F328EEQ33749179-E41C4719-0704-46F0-A6DF-B537C882A478Q35017714-E499070E-4F2D-49A7-A3EA-C748EBB87642Q37359637-23792507-1B07-4DEB-B7CF-3D054182194DQ37720395-51E63EA2-BA25-4809-A7B7-865366120292Q37722775-E447CC1D-F421-47A3-A446-77570804AEB7Q38213291-2D3C45FF-0CE0-43E5-AB56-89A29DF838D4Q38640309-06F8FC33-8FB4-4CAA-8578-EE80EC0FAF3EQ38830333-9CD49F50-45D4-44BD-BD37-078869DC3378Q39055066-14C910EF-537F-498B-A155-C3CE888677C6Q41670111-D1E49ABC-590D-4809-A575-7ADEEFA4DA52Q47158118-FB0C8BE5-2F0C-4D0E-9554-1BB75F30635AQ47344652-0B26966A-36AB-4CD6-BA76-33AE7658ADD5Q47792970-95092894-21BA-43B7-8436-39212FD35A1DQ48152221-AA1CC932-5AC6-4FEF-81AA-7734AC66F6B0Q56366358-43F783DA-DE50-4A4B-BFDD-E263948A15E0
P2860
Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Hip bone loss is attenuated wi ...... d RCT in postmenopausal women.
@en
type
label
Hip bone loss is attenuated wi ...... d RCT in postmenopausal women.
@en
prefLabel
Hip bone loss is attenuated wi ...... d RCT in postmenopausal women.
@en
P2093
P2860
P356
P1476
Hip bone loss is attenuated wi ...... d RCT in postmenopausal women.
@en
P2093
Adrian D Wood
Alison J Black
David M Reid
Frank Thies
Helen M Macdonald
Karen R Secombes
Lorna S Aucott
William D Fraser
William G Simpson
P2860
P304
P356
10.1002/JBMR.1959
P577
2013-10-01T00:00:00Z